CRA analyzed market definition in antitrust litigation concerning a product in the non-opioid pain category. In defining the relevant antitrust market, our work accounted for indicators of competition among branded pharmaceutical products, including market positioning, factors driving physician choice, development of new approved indications, and competition for formulary listing.
Competition Series – Economist Edition – Part 1
In the latest episode of The Competition Series: Economist Edition from Al Tamimi & Company, Muath Masri joins Omar Obeidat and Mariam Sabet for conversations...